Thompson Davis & Co’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-8
Closed -$1K 810
2018
Q2
$1K Hold
8
﹤0.01% 658
2018
Q1
$1K Hold
8
﹤0.01% 612
2017
Q4
$1K Sell
8
-474
-98% -$65.1K ﹤0.01% 651
2017
Q3
$66K Sell
482
-354
-42% -$53.4K 0.12% 180
2017
Q2
$147K Buy
836
+486
+139% +$69.1K 0.24% 95
2017
Q1
$42K Buy
350
+100
+40% +$10.4K 0.06% 280
2016
Q4
$24K Hold
250
0.04% 441
2016
Q3
$23K Sell
250
-667
-73% -$66.9K 0.04% 427
2016
Q2
$99K Buy
917
+667
+267% +$78.1K 0.16% 150
2016
Q1
$30K Sell
250
-7,143
-97% -$750K 0.04% 336
2015
Q4
$880K Buy
7,393
+6,968
+1,640% +$899K 1.24% 8
2015
Q3
$72K Sell
425
-470
-53% -$90.1K 0.1% 198
2015
Q2
$173K Buy
895
+135
+18% +$25.1K 0.2% 112
2015
Q1
$113K Buy
760
+660
+660% +$100K 0.14% 162
2014
Q4
$16K Sell
100
-17
-15% -$2.45K 0.02% 596
2014
Q3
$17K Buy
117
+17
+17% +$2.46K 0.02% 526
2014
Q2
$13K Sell
100
-783
-89% -$99.4K 0.02% 458
2014
Q1
$108K Sell
883
-1,875
-68% -$203K 0.18% 146
2013
Q4
$293K Buy
+2,758
New +$268K 0.44% 52

Other funds holding SRGA

Thompson Davis & Co's SRGA Position: Q3 2018 in Review

Thompson Davis & Co sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2018, closing a stake of 8 shares — an estimated $1K sold.

Thompson Davis & Co first reported a position in SRGA in Q4 2013 and held it in 19 quarters. The position peaked at $880K in Q4 2015. 107 funds tracked by Wall St. Rank hold SRGA as of Q3 2018.

  • Thompson Davis & Co reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 8 Surgalign Holdings, Inc. Common Stock shares in Q3 2018, an estimated $1K.
  • Thompson Davis & Co first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2013 and held it in 19 quarters.
  • Thompson Davis & Co's Surgalign Holdings, Inc. Common Stock position peaked at $880K in Q4 2015.
  • 107 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.